A low concentration of genistein induces estrogen receptor-alpha and insulin-like growth factor-I receptor interactions and proliferation in uterine leiomyoma cells

Xudong Di, X Di, L Yu, Linda Chia‐Hui Yu, A B Moore, Alicia B. Moore, Lisandra Castro, L Castro, X Zheng, Xiaolin Zheng, T Hermon, Tonia Hermon, D Dixon, Darlene Dixon
Human Reproduction · 2008 · vol. 23(8) , pp. 1873–1883 · doi:10.1093/humrep/den087 · PMID:18492705 · PMC2733822 · W2111808706
Lab / animal OA: bronze CC0 ⤵ 9 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

Low-concentration genistein stimulates uterine leiomyoma cell proliferation by inducing interactions between estrogen receptor-alpha and the IGF-I receptor, activating ERK/MAPK signaling.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND: Previously, we found that genistein at low concentrations stimulates the growth of human uterine leiomyoma (LM) cells, but not uterine smooth muscle (myometrial) cells (SMC). The aim of this study was to understand the molecular mechanism whereby genistein causes hyperproliferation of LM cells. METHODS: The effects of genistein at 1 microg/ml on LM cells and SMC were evaluated using estrogen response element gene reporter, real-time RT-PCR, western blot, immunoprecipitation and cell proliferation assays. RESULTS: Elevated estrogen receptor (ER) transactivation, increased mRNA expression of early estrogen-responsive genes, progesterone receptor and insulin-like growth factor-I (IGF-I), and decreased protein levels of ER-alpha (ER alpha) were found in genistein-treated LM cells, but not SMC. Additionally, extracellular regulated kinase (ERK), Src homology/collagen (Shc) and ER alpha were transiently activated, and interactions between ER alpha and IGF-I receptor (IGF-IR) were rapidly induced by genistein in LM cells. Using ER antagonist ICI 182,780 and MAPK/ERK kinase (MEK) inhibitor PD98059, we found that these early events were inhibited and the proliferative effect of genistein on LM cells was abrogated. CONCLUSIONS: ER alpha is involved in the transient activation of ERK/mitogen activated protein kinase (MAPK) by genistein via its early association with IGF-IR, leading to hyper-responsiveness of LM cells and confirming that ER signaling is enhanced by activation of ERK/MAPK in LM cells.

My notes (saved in your browser only)

MeSH descriptors

Estrogen Receptor alpha Genistein Leiomyoma Receptor, IGF Type 1 Uterine Neoplasms Cell Line Cell Line, Tumor Cell Proliferation Cell Proliferation Estrogen Receptor alpha Estrogen Receptor alpha Estrogen Receptor beta Estrogen Receptor beta Extracellular Signal-Regulated MAP Kinases Extracellular Signal-Regulated MAP Kinases Female Genistein Humans Insulin-Like Growth Factor I Insulin-Like Growth Factor I

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (70)

Cited by (8)

Source provenance

openalex
last seen: 2026-05-13T20:07:10.637958+00:00
pubmed
last seen: 2026-10-08T21:05:28.665087+00:00
License: CC0 · commercial use OK